AlphAIalphai — Financial news for AI agents
scanx.tradeAUG 174 min read

W H Brady Q1 Results: Net profit up 160% YoY to ₹172 lakh

W H Brady & Company Limited reported Q1 FY27 standalone net profit of ₹172.05 lakh, up from a ₹107.70 lakh loss in Q1 FY26, with standalone revenue from operations up 41.6% to ₹1,090.71 lakh. Consolidated net profit was ₹249.24 lakh, slightly down from ₹261.64 lakh. Consolidated revenue from operations fell 14% to ₹2,270.32 lakh. Board approved results on Aug 13, 2026.

Original reporting
scanx.trade
Published Aug 17, 2026, 7:55 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 11:21 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
W H Brady Q1 Results: Net profit up 160% YoY to ₹172 lakh — source image
Source · scanx.trade
Decision brief

The 30-second read

Med
01

Why it matters

Traders may reprice the stock based on the magnitude of the standalone swing to profit, while also discounting it if consolidated revenue contraction persists. The tax provisioning change and MAT credit claim add an additional layer to earnings quality assessment.

02

Market read

A quantified Q1FY27 turnaround on a standalone basis, contrasted with consolidated revenue and EPS declines, creates a mixed catalyst for near-term positioning.

03

What to watch

Tax provisioning under the Income Tax Act, 2025 (Section 201) and MAT credit usage could influence quarter-to-quarter comparability of profitability.

Relevance 7/10Novelty 6/10Timing: pre-market today (results reported for Q1FY27, board approved Aug 13, 2026)

Background

The company’s Q1FY27 results show a large standalone profitability rebound alongside weaker consolidated revenue, plus a disclosed change in tax provisioning methodology effective April 1, 2026.

Market effects

Sector

Signals potential normalization in the company’s core operations, but highlights risk of earnings dispersion between parent and subsidiaries.

Regional

Limited direct regional spillover; includes a Mumbai leasehold-to-freehold conversion payment.

Global

Low, India-specific corporate results with no cross-border deal or regulatory action.

Counterpoint

What could challenge this read

The consolidated picture deteriorated (revenue from operations -14%, consolidated EPS down), so the standalone turnaround may not translate into group earnings power.

Key entities

  • company
    W H Brady & Company Limited

    Reported Q1FY27 standalone net profit of ₹172.05 lakh and disclosed tax provisioning changes effective April 1, 2026.

  • subsidiary
    Brady & Morris Engineering Company Limited

    Cited as the likely source of consolidated headwinds offsetting parent gains during the quarter.

  • auditor
    M/s. J. G. Verma & Co.

    Issued an unmodified opinion on the financial results.

  • government counterparty
    District Collector of Mumbai

    Received ₹976.61 lakh conversion premium for leasehold rights at Brady House to freehold.

Read at source← All news

Related articles

AUG 6
$BRCMed

BRADY CORP (BRC): Completion of Acquisition or Disposition of Assets

BRADY CORP (BRC) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 2 exhibit101-notepurchaseagr.htm NOTE PURCHASE AGREEMENT Document EXHIBIT 10.1 Brady Corporation $250,000,000 Senior Notes, Series A $300,000,000 Senior Notes, Series B $250,000,000 Senior Notes, Series C ______________ Note Purchase Agreement ______________ Dated August

SEC EDGAR 8-K4 min
JUL 28
$BRCMedAI 8/10

Brady sells $800M bonds to fund Honeywell unit acquisition - Bloomberg By Investing.com

Brady Corp. (NYSE:BRC) sold $800 million of private-placement bonds with maturities of 5 to 10 years to fund its April $1.4 billion acquisition of Honeywell International’s productivity solutions and services (PSS) business, according to Bloomberg via Investing.com. The largest tranche was a $300 million seven-year note priced at 1.25 points over Treasuries. BMO Capital Markets arranged the deal.

investing.com4 min
AUG 24
$SPGMedAI 8/10

Why Simon Property Group’s malls are attracting more retailers

Simon Property Group reported strong Q2 results with revenue up 20% to $1.79B. CEO Eli Simon noted high retailer demand, 1,200 leases signed, and 17% positive rent spreads. Portfolio occupancy remained at 96%, with re-leased Saks Off 5th space expected to yield higher rents. FFO was flat at $1.185B, while net income decreased 13.1% to $483.1M. Sales productivity rose 14% to $838 per sq ft.

insideretail.asia3 min
AUG 24
$GILDHighAI 8/10

Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?

Gilead Sciences (GILD) reported Q2 2026 with double-digit growth in commercial portfolio sales, but posted a significant loss due to $11.2B in R&D expenses from acquisitions. HIV sales rose 12% to $5.7B, while non-HIV areas like liver disease and cancer treatments also showed growth. The company raised its 2026 sales guidance and made strategic acquisitions, but faces risks from clinical development and financial obligations.

insidermonkey.com3 min
AUG 24
$ABBVMedAI 8/10

AbbVie’s Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated?

AbbVie (NYSE:ABBV) reported Q2 2026 revenue of $16.99B, up 10.2%, driven by immunology and neuroscience. Skyrizi and Rinvoq revenues grew 24.4% and 24.5% respectively, offsetting Humira's 35.9% decline. However, concentration risk exists as these two products made up 47% of revenue. Oncology and aesthetics showed weaker performance, with oncology revenue down 1.5%. Adjusted EPS rose 22.9% to $3.65.

yahoo.com3 min